These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25990531)

  • 1. Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.
    Foldvari A; Kovacs N; Sipos V; Merth G; Vincze F; Szucs M; Sandor J
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):459-64. PubMed ID: 25990531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
    Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
    Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
    Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
    Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Cea G; Martinez D; Salinas R; Vidal C; Hoffmeister L; Stuardo A
    Acta Neurol Scand; 2018 Oct; 138(4):338-343. PubMed ID: 29845611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
    Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
    Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of myasthenia gravis in the Catalan county of Osona.
    Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
    Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide epidemiological study of myasthenia gravis in Latvia.
    Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
    Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
    Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
    Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
    Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.
    Andersen JB; Engeland A; Owe JF; Gilhus NE
    Eur J Neurol; 2010 Dec; 17(12):1445-50. PubMed ID: 20491896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender prevalence in childhood multiple sclerosis and myasthenia gravis.
    Haliloglu G; Anlar B; Aysun S; Topcu M; Topaloglu H; Turanli G; Yalnizoglu D
    J Child Neurol; 2002 May; 17(5):390-2. PubMed ID: 12150589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.